GOLGA6L6
gene geneOn this page
Also known as FLJ36131
Summary
GOLGA6L6 (golgin A6 family like 6 (gene/pseudogene), HGNC:37225) is a protein-coding gene on chromosome 15q11.2, encoding Golgin subfamily A member 6-like protein 6 (A8MZA4).
At a glance
- Clinical variants (ClinVar): 156 total
- MANE Select transcript:
NM_001145004
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37225 |
| Approved symbol | GOLGA6L6 |
| Name | golgin A6 family like 6 (gene/pseudogene) |
| Location | 15q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ36131 |
| Ensembl gene | ENSG00000277322 |
| Ensembl biotype | protein_coding |
| Entrez | 727832 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000619213
RefSeq mRNA: 1 — MANE Select: NM_001145004
NM_001145004
CCDS: CCDS45184
Canonical transcript exons
ENST00000619213 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003713988 | 20538636 | 20538686 |
| ENSE00003726781 | 20531856 | 20533602 |
| ENSE00003733413 | 20538252 | 20538358 |
| ENSE00003734625 | 20541548 | 20541800 |
| ENSE00003738024 | 20536814 | 20536872 |
| ENSE00003741243 | 20539773 | 20539901 |
| ENSE00003743192 | 20538454 | 20538547 |
| ENSE00003744609 | 20536342 | 20536483 |
| ENSE00003747452 | 20534259 | 20535689 |
Expression profiles
Bgee: expression breadth tissue_specific, 6 present calls, max score 64.34.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 64.34 | gold quality |
| testis | UBERON:0000473 | 63.48 | gold quality |
| right testis | UBERON:0004534 | 62.54 | gold quality |
| sural nerve | UBERON:0015488 | 48.57 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| apex of heart | UBERON:0002098 | 36.10 | gold quality |
| primary visual cortex | UBERON:0002436 | 35.84 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 35.46 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| prefrontal cortex | UBERON:0000451 | 31.70 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.24 | gold quality |
| frontal cortex | UBERON:0001870 | 28.96 | gold quality |
| lymph node | UBERON:0000029 | 28.73 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| monocyte | CL:0000576 | 27.85 | gold quality |
| leukocyte | CL:0000738 | 27.83 | gold quality |
| urinary bladder | UBERON:0001255 | 27.75 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| blood | UBERON:0000178 | 26.94 | silver quality |
| islet of Langerhans | UBERON:0000006 | 26.88 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| pancreas | UBERON:0001264 | 26.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
72 targeting GOLGA6L6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-23A-5P | 99.94 | 65.39 | 468 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
Cross-species orthologs
0 orthologs
Paralogs (10): GOLGA6L2 (ENSG00000174450), GOLGA6L4 (ENSG00000184206), GOLGA6L9 (ENSG00000197978), GOLGA6L25 (ENSG00000227717), GOLGA6L24 (ENSG00000237850), GOLGA6L7 (ENSG00000261649), GOLGA6L26 (ENSG00000273756), GOLGA6L1 (ENSG00000273976), GOLGA6L22 (ENSG00000277865), GOLGA6L10 (ENSG00000278662)
Protein
Protein identifiers
Golgin subfamily A member 6-like protein 6 — A8MZA4 (reviewed: A8MZA4)
All UniProt accessions (1): A8MZA4
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GOLGA6 family.
RefSeq proteins (1): NP_001138476* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026737 | GOLGA6L | Family |
UniProt features (12 total): region of interest 5, compositionally biased region 5, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MZA4-F1 | 72.76 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 14 (showing top):
chr15q11, MIR196A_1_3P, MIR1827, MIR1252_3P, MIR4666A_5P, MIR3064_3P, MIR4426, MIR4640_5P, MIR6747_3P, MIR4726_5P, MIR1243, MIR23B_5P, MIR23A_5P, ZSCAN4_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
603 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GOLGA6L6 | TEX55 | Q96M34 | 602 |
| GOLGA6L6 | OR2T33 | Q8NG76 | 474 |
| GOLGA6L6 | OR4M2 | Q8NGB6 | 447 |
| GOLGA6L6 | OR4N4 | Q8N0Y3 | 445 |
| GOLGA6L6 | ZNF541 | Q9H0D2 | 418 |
| GOLGA6L6 | ODF4 | Q2M2E3 | 396 |
| GOLGA6L6 | ADGRD2 | Q7Z7M1 | 394 |
| GOLGA6L6 | CHLSN | Q9BRJ6 | 368 |
| GOLGA6L6 | ADPRHL1 | Q8NDY3 | 359 |
| GOLGA6L6 | DTHD1 | Q6ZMT9 | 357 |
| GOLGA6L6 | IGSF9 | Q9P2J2 | 323 |
| GOLGA6L6 | GOLGA8CP | A6NN73 | 314 |
| GOLGA6L6 | C8orf82 | Q6P1X6 | 304 |
| GOLGA6L6 | TRIM49C | P0CI26 | 301 |
| GOLGA6L6 | NOSTRIN | Q8IVI9 | 292 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GOLGA6L2 | GOLGA6L6 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A1B0GV03, A6NEF3, A6NEM1, A6NI86, A8MZA4, B4DH59, D3YVF0, F6QRE9, H0YKK7, H0YM25, P0C6Y7, P0C7A2, P0DX00, P0DX01, P0DX02, P14590, P21263, P22793, P24587, P24710, P48997, P48998, Q07283, Q0II65, Q0P6D6, Q13342, Q3BBV2, Q4R9C9, Q5W0A0, Q6AXX0, Q6NSX1, Q6P5H2, Q6P902, Q86T75, Q8CHD8, Q8N2N9, Q8N660, Q8N7Z2
Diamond homologs: A0A1B0GV03, A1IH00, A6NC78, A6NCC3, A6NDK9, A6NDN3, A6NEF3, A6NEM1, A6NI86, A6NN73, A7E2F4, A8MQT2, A8MZA4, F8WBI6, H0YKK7, H0YM25, H3BPF8, H3BSY2, H3BV12, I6L899, P0CG33, P0CJ92, P0DX00, P0DX01, P0DX02, P0DX52, P0DX53, Q08379, Q62839, Q8N7Z2, Q8N9W4, Q921M4, Q9NYA3, A6NMD2, D6RF30, H3BQL2, Q0D2H9, Q9HBQ8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
156 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 138 |
| Likely benign | 10 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1048 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:20533742:T:TA | donor_gain | 1.0000 |
| 15:20536337:CTCA:C | donor_loss | 1.0000 |
| 15:20536338:TCAC:T | donor_loss | 1.0000 |
| 15:20536339:CA:C | donor_loss | 1.0000 |
| 15:20536340:A:AC | donor_gain | 1.0000 |
| 15:20536340:ACCT:A | donor_loss | 1.0000 |
| 15:20536341:C:CC | donor_gain | 1.0000 |
| 15:20536479:TTATG:T | acceptor_gain | 1.0000 |
| 15:20536480:TATG:T | acceptor_gain | 1.0000 |
| 15:20536481:ATG:A | acceptor_gain | 1.0000 |
| 15:20536483:GC:G | acceptor_loss | 1.0000 |
| 15:20536484:C:CC | acceptor_gain | 1.0000 |
| 15:20536484:CTAT:C | acceptor_loss | 1.0000 |
| 15:20536486:A:C | acceptor_gain | 1.0000 |
| 15:20536491:C:CT | acceptor_gain | 1.0000 |
| 15:20536491:C:T | acceptor_gain | 1.0000 |
| 15:20536492:A:T | acceptor_gain | 1.0000 |
| 15:20536497:C:CT | acceptor_gain | 1.0000 |
| 15:20536498:A:T | acceptor_gain | 1.0000 |
| 15:20536499:G:C | acceptor_gain | 1.0000 |
| 15:20536499:G:GC | acceptor_gain | 1.0000 |
| 15:20536812:A:AC | donor_gain | 1.0000 |
| 15:20536813:C:CC | donor_gain | 1.0000 |
| 15:20536818:T:A | donor_gain | 1.0000 |
| 15:20538250:AC:A | donor_gain | 1.0000 |
| 15:20538251:CC:C | donor_gain | 1.0000 |
| 15:20538631:CTCA:C | donor_loss | 1.0000 |
| 15:20538632:TCA:T | donor_loss | 1.0000 |
| 15:20538633:CA:C | donor_loss | 1.0000 |
| 15:20538635:C:CT | donor_loss | 1.0000 |
AlphaMissense
4970 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:20536382:A:G | L235P | 0.938 |
| 15:20538501:A:G | L130P | 0.925 |
| 15:20538522:A:G | L123P | 0.922 |
| 15:20538331:A:G | L155P | 0.919 |
| 15:20536445:A:G | L214P | 0.918 |
| 15:20536466:A:G | L207P | 0.904 |
| 15:20538343:A:G | L151P | 0.902 |
| 15:20536433:A:G | L218P | 0.898 |
| 15:20535649:A:G | L262P | 0.887 |
| 15:20536826:A:G | L197P | 0.887 |
| 15:20536362:C:G | A242P | 0.886 |
| 15:20538312:A:C | F161L | 0.886 |
| 15:20538312:A:T | F161L | 0.886 |
| 15:20538314:A:G | F161L | 0.886 |
| 15:20535628:A:G | L269P | 0.878 |
| 15:20538479:G:C | S137R | 0.872 |
| 15:20538479:G:T | S137R | 0.872 |
| 15:20538481:T:G | S137R | 0.872 |
| 15:20536370:A:G | L239P | 0.865 |
| 15:20538323:A:G | S158P | 0.860 |
| 15:20538525:A:G | I122T | 0.860 |
| 15:20538640:A:G | L113P | 0.838 |
| 15:20538489:A:G | L134P | 0.828 |
| 15:20538260:C:G | A179P | 0.826 |
| 15:20538289:A:G | L169P | 0.821 |
| 15:20538493:C:G | A133P | 0.821 |
| 15:20538547:C:G | A115P | 0.821 |
| 15:20538472:C:G | A140P | 0.816 |
| 15:20538513:T:G | Q126P | 0.814 |
| 15:20536838:A:G | L193P | 0.804 |
dbSNP variants (sampled 300 via entrez): RS1001155933 (15:20534560 TCCC>T,TCC), RS1001461630 (15:20537792 A>C,G), RS1004007329 (15:20543440 A>G,T), RS1007184696 (15:20532340 A>G), RS1007775748 (15:20542009 T>C), RS1008007579 (15:20538236 C>A,T), RS1008327233 (15:20539753 C>T), RS1009812888 (15:20538009 G>A,C,T), RS1009844672 (15:20539518 A>T), RS1013617079 (15:20534424 C>G), RS1013724870 (15:20532615 A>C), RS1017509048 (15:20542559 A>G), RS1017898869 (15:20540071 GA>G,GAA), RS1018453484 (15:20538250 A>G), RS1019925927 (15:20535767 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| chloropicrin | increases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.